LMCG INVESTMENTS, LLC - SYNAGEVA BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 133 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 3.68 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
LMCG INVESTMENTS, LLC ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$5,496,000
+119.4%
56,342
+108.6%
0.12%
+109.1%
Q4 2014$2,505,000–27,005–0.06%–
 Download
Other shareholders

There were no reported owners of SYNAGEVA BIOPHARMA CORP in Q1 2015.

NameSharesValueWeighting ↓
View complete list of SYNAGEVA BIOPHARMA CORP shareholders